OIVITA: Observatory on Impact of Life Styles on Health Outcomes

Sponsor
Guido Iaccarino (Other)
Overall Status
Recruiting
CT.gov ID
NCT03305276
Collaborator
(none)
1,500
1
120
12.5

Study Details

Study Description

Brief Summary

The present is an observational study conducted on the general population in villages of Southern Italy every year during the world hypertension day. So far, A total of 412 persons (193 males and 219 female, 14-85 years) were recruited during the XI and XII World Hypertension Day (2015 and 2016). The study was approved by the relevant institutional Ethical Committee of Salerno University.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    In occasion of the World Hypertension Day in may , boots are organized in the major squares of the southern italy villages, and volunteers of the Medical School of Salerno collect through means of questionnaires, anamnestic data and dietary habits, and measure blood pressure after 5 minutes in the sitting position, 3 times with an interval of 2 minutes using validated, ESH approved electronic oscillometer (A100, Microlife, Italy), according to the ESC/ESH guidelines. Other questions regard previous cardiovascular conditions or events (coronary heart disease) and cardiovascular accidents (TIA and stroke). Eventual drug treatment and Vitamin D supplementation is also annotated. A venous blood sample is drawn from the antecubital vein and blood is stored for biochemical analysis at the University Hospital Centralized Service. Data are digitally stored for analysis.

    Anamnestic and biochemical data regarding age, sex-specific cholesterol, HDL cholesterol, systolic BP and cigarette smoking pre-existing conditions and way of life are used for the calculation of cardiovascular risk according to the Framingham Cardiovascular Risk Score. Familiarity for cardiovascular disease is defined as cardiovascular events in parents and siblings less than 50 years old.

    The validated questionnaire alternate Mediterranean Diet Score (aMed), is administered to assess adherence to the Mediterranean Diet . Laboratory assessment of blood samples. A venous blood sample was collected in two tubes of 5.0 ml and centrifuged in the day. The time of the last meal was recorded during the data collection. Blood glucose, insulin, blood urea nitrogen (BUN), creatinine, calcium, phosphorus, total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, 25(OH)D, PTH, Vitamin B-12 and folic acid are assessed. Glomerular filtration rate (GFRs) is estimated using the equation of Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) .

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    1500 participants
    Observational Model:
    Ecologic or Community
    Time Perspective:
    Retrospective
    Official Title:
    Evaluation of the Impact of Mediterranean Lifestyle and Diet on Intermediate and Final Endpoints of Health
    Actual Study Start Date :
    May 16, 2014
    Anticipated Primary Completion Date :
    Jul 16, 2020
    Anticipated Study Completion Date :
    May 16, 2024

    Arms and Interventions

    Arm Intervention/Treatment
    general population

    the study is open to all population, (14-90 years, male/female) to verify the impact of lifestyles (mediterranean style) on intermediate and hard endpoint.

    Outcome Measures

    Primary Outcome Measures

    1. cardiovascular events [10 year]

      Presence of events in the anamnesis of subjects enrolled

    Secondary Outcome Measures

    1. cardiovascular risk [10 years]

      Framingham Risk Score

    Other Outcome Measures

    1. vitamin D profile [10 years]

      vitamin d serum levels will be assessed and compared to the life style

    2. vitamin B12 profile [10 years]

      vitamin b12 serum levels will be assessed and compared to the life style

    3. Folic Acid profile [10 years]

      folic acid serum levels will be assessed and compared to the life style

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    14 Years to 100 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • General population
    Exclusion Criteria:
    • Subjects who do not sign informed consent and do not give authorization will be excluded from the study

    • Subjects fed through parenteral feeding

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 San Giovanni e Ruggi Hospital Salerno Italy 84100

    Sponsors and Collaborators

    • Guido Iaccarino

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Guido Iaccarino, Associate Professor of Internal Medicine, Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona
    ClinicalTrials.gov Identifier:
    NCT03305276
    Other Study ID Numbers:
    • 1234
    First Posted:
    Oct 9, 2017
    Last Update Posted:
    Oct 9, 2017
    Last Verified:
    Oct 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Guido Iaccarino, Associate Professor of Internal Medicine, Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona

    Study Results

    No Results Posted as of Oct 9, 2017